Join Diasorin June 4 – 7 at the ASM Microbe 2026 – Booth #1301
ASM Microbe brings the global microbiology and infectious disease communities together to share knowledge and drive innovation. Diasorin is proud to support this mission with integrated immunodiagnostic and molecular solutions designed to deliver reliable results, adapt to evolving laboratory needs, and help address today’s most pressing healthcare challenges.
At Booth #1301, discover how our portfolio of specialty assays, immunodiagnostics, and molecular solutions help laboratories deliver timely, actionable results.
Explore solutions including:
- Immunodiagnostics Portfolio – Comprehensive assay offerings supporting infectious disease, specialty testing, and emerging diagnostic needs
- LIAISON® – Trusted immunodiagnostic testing delivering high-quality, automated specialty assay results with proven reliability
- Simplexa® – Flexible molecular testing designed to streamline workflows and provide rapid answers when time matters most
Together, our solutions support:
- Diagnostic stewardship through the right test at the right time
- Optimized laboratory efficiency and workflow flexibility
- Improved clinical confidence and patient outcomes
Our Immunology and Molecular teams will be onsite to discuss how these solutions can support your laboratory’s evolving needs.
Live Recording of the Beyond the Result Podcast
Friday, June 5, 12 p.m. ET, Industry and Science Theater A
Join us for a live recording of the Beyond the Result podcast, featuring expert perspectives and engaging discussion on key topics shaping infectious disease diagnostics.
This session will be recorded live with an audience and released as a future episode—giving attendees a unique opportunity to be part of the conversation.
Explore session details and join us.
Making a Case for Host-Response Diagnostics: Real-World Impact, Workflow Integration, and Economics of MeMed BV
Friday, June 5, 1:00 p.m. ET, Industry and Science Theater A
Diagnostic uncertainty in suspected infection drives unnecessary admissions, prolonged length of stay, and inappropriate antimicrobial use, while laboratories face increasing pressure to demonstrate clinical and economic value without clear reimbursement pathways.
This session explores the real-world utility of LIAISON® MeMed BV, a host-response assay that differentiates bacterial and viral infections, through the lens of implementation, workflow integration, and health economics. Speakers will present emerging evidence and share practical experience from a U.S. healthcare system, highlighting how the test influences clinical decision-making, patient disposition, and operational metrics such as admissions, emergency department throughput, and length of stay.
The program will also address a central question for microbiology leaders: how to evaluate and justify adoption when value extends beyond the laboratory cost center. By combining real-world data with economic insights, this session provides a practical framework for assessing the role of host-response diagnostics in clinical pathways and value-based care.
Clinical Microbiology Virtual Journal Club
Friday, June 5, 3:15 p.m. ET, Career Catalyst Hub in the Exhibit Hall
Enjoy a review of a recent peer‑reviewed publication and a discussion on age‑stratified respiratory pathogen epidemiology, clinical applications, stewardship, and panel design.
Featured Publication: Age‑Stratified Epidemiology of Respiratory Pathogens and the Value of Customizable Syndromic Testing Using the LIAISON PLEX® Respiratory Flex Assay
Gonzalez K, Amicarelli G. (2025) Journal of Molecular Diagnostics, 27: 809–818
Learn more: Clinical Microbiology Virtual Journal Club | ASM.org
Add Diasorin Booth #1301 to your ASM Microbe agenda and connect with our team onsite. We look forward to seeing you there.
